A “team effort” for discovering how to diagnose and treat amyloidosis, a rare protein-folding disorder. Amyloidosis is a rare disorder that occurs when an abnormal amyloid protein deposits in organs and tissues, interfering with their ability to function normally. There are approximately 30 different types of amyloidosis, and the disease can either be systemic or (read more)
Entrepreneurship
From Discovery to Biopharmaceutical Startup: UTGSM Innovators Demonstrate Progress in Therapeutics for Systemic Amyloidosis
A team of researchers from the University of Tennessee Graduate School of Medicine has spent more than two decades investigating systemic amyloidosis, a rare and often fatal disorder with few treatments. Their work played an integral role in moving discoveries out of the lab and into clinical trials, helping launch a biopharmaceutical company focused on (read more)
Supporting the Entrepreneurial Community: UTRF Helps Launch Six Technology Startups in FY 2020
Entrepreneurship sits at the heart of innovation, often driving commercialization and economic development in the state. The University of Tennessee has a wealth of innovators across the UT System who are constantly contributing their passions and skills to bring new ideas, goods, and services to the market. Committed to supporting entrepreneurial activity in the region, (read more)